BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim HY, Kim YM, Hong S. DNAJB9 suppresses the metastasis of triple-negative breast cancer by promoting FBXO45-mediated degradation of ZEB1. Cell Death Dis 2021;12:461. [PMID: 33966034 DOI: 10.1038/s41419-021-03757-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Li Z, Yang H, Zhang X, Zhang X, Huang Y, Dai X, Shi L, Zhou G, Wei J, Ding Q. Kinesin family member 23, regulated by FOXM1, promotes triple negative breast cancer progression via activating Wnt/β-catenin pathway. J Exp Clin Cancer Res 2022;41:168. [DOI: 10.1186/s13046-022-02373-7] [Reference Citation Analysis]
2 Kim HY, Hong S. Multi-Faceted Roles of DNAJB Protein in Cancer Metastasis and Clinical Implications. Int J Mol Sci 2022;23. [PMID: 36499297 DOI: 10.3390/ijms232314970] [Reference Citation Analysis]
3 Feng Li, Jiahao Ma, Cheng Yan, Yonghua Qi. ER stress-related mRNA-lncRNA co-expression gene signature predicts the prognosis and immune implications of esophageal cancer. Am J Transl Res 2022;14. [PMID: 36505280] [Reference Citation Analysis]
4 Zhou Y, Tang Y, Luo J, Yang Y, Zang H, Ning Y, Zheng H, Fan S, Wen Q. Elevated of HSP90 associates with expression of EGFR levels and predicts poor prognosis in non-small cell lung cancer patients.. [DOI: 10.21203/rs.3.rs-2101621/v1] [Reference Citation Analysis]
5 Wang Q, Wu L, Cao R, Gao J, Chai D, Qin Y, Ma L, Wu S, Tao Y, Ma J, Wang ZW. Fbxo45 promotes the malignant development of esophageal squamous cell carcinoma by targeting GGNBP2 for ubiquitination and degradation. Oncogene 2022. [PMID: 36127399 DOI: 10.1038/s41388-022-02468-7] [Reference Citation Analysis]
6 Cao T, Cui Y, Wang Y, Wu L, Yu K, Chen K, Xia J, Li Y, Wang ZP, Ma J. CACNA1C-AS2 inhibits cell proliferation and suppresses cell migration and invasion via targeting FBXO45 and PI3K/AKT/mTOR pathways in glioma. Apoptosis 2022. [PMID: 36038736 DOI: 10.1007/s10495-022-01764-7] [Reference Citation Analysis]
7 Kaida A, Iwakuma T. Impacts of Heat Shock Protein 40/J-domain Proteins on Cancer Progression and p53 Activity. Thermal Med 2022;38:33-50. [DOI: 10.3191/thermalmed.38.33] [Reference Citation Analysis]
8 Huang Z, Zhang Z, Zhou C, Liu L, Huang C. Epithelial–mesenchymal transition: The history, regulatory mechanism, and cancer therapeutic opportunities. MedComm 2022;3. [DOI: 10.1002/mco2.144] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
9 Alam M, Hasan GM, Ansari MM, Sharma R, Yadav DK, Hassan MI. Therapeutic implications and clinical manifestations of thymoquinone. Phytochemistry 2022. [DOI: 10.1016/j.phytochem.2022.113213] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
10 Wu L, Yu K, Chen K, Zhu X, Yang Z, Wang Q, Gao J, Wang Y, Cao T, Xu H, Pan X, Wang L, Xia J, Li Y, Wang ZP, Ma J. Fbxo45 facilitates pancreatic carcinoma progression by targeting USP49 for ubiquitination and degradation. Cell Death Dis 2022;13:231. [PMID: 35279684 DOI: 10.1038/s41419-022-04675-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
11 Daverkausen-Fischer L, Pröls F. The function of the co-chaperone ERdj4 in diverse (patho-)physiological conditions. Cell Mol Life Sci 2021;79:9. [PMID: 34950970 DOI: 10.1007/s00018-021-04082-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Kaida A, Iwakuma T. Regulation of p53 and Cancer Signaling by Heat Shock Protein 40/J-Domain Protein Family Members. Int J Mol Sci 2021;22:13527. [PMID: 34948322 DOI: 10.3390/ijms222413527] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]